|
US3995631A
(en)
|
1971-01-13 |
1976-12-07 |
Alza Corporation |
Osmotic dispenser with means for dispensing active agent responsive to osmotic gradient
|
|
US3760984A
(en)
|
1971-09-29 |
1973-09-25 |
Alza Corp |
Osmotically powered agent dispensing device with filling means
|
|
US3845770A
(en)
|
1972-06-05 |
1974-11-05 |
Alza Corp |
Osmatic dispensing device for releasing beneficial agent
|
|
US3916899A
(en)
|
1973-04-25 |
1975-11-04 |
Alza Corp |
Osmotic dispensing device with maximum and minimum sizes for the passageway
|
|
US3923426A
(en)
|
1974-08-15 |
1975-12-02 |
Alza Corp |
Electroosmotic pump and fluid dispenser including same
|
|
US4036228A
(en)
|
1975-09-11 |
1977-07-19 |
Alza Corporation |
Osmotic dispenser with gas generating means
|
|
US3987790A
(en)
|
1975-10-01 |
1976-10-26 |
Alza Corporation |
Osmotically driven fluid dispenser
|
|
US4016880A
(en)
|
1976-03-04 |
1977-04-12 |
Alza Corporation |
Osmotically driven active agent dispenser
|
|
US4111203A
(en)
|
1976-11-22 |
1978-09-05 |
Alza Corporation |
Osmotic system with means for improving delivery kinetics of system
|
|
US4111202A
(en)
|
1976-11-22 |
1978-09-05 |
Alza Corporation |
Osmotic system for the controlled and delivery of agent over time
|
|
US4203442A
(en)
|
1977-08-29 |
1980-05-20 |
Alza Corporation |
Device for delivering drug to a fluid environment
|
|
US4203440A
(en)
|
1978-10-23 |
1980-05-20 |
Alza Corporation |
Device having variable volume chamber for dispensing useful agent
|
|
US4210139A
(en)
|
1979-01-17 |
1980-07-01 |
Alza Corporation |
Osmotic device with compartment for governing concentration of agent dispensed from device
|
|
US4360019A
(en)
|
1979-02-28 |
1982-11-23 |
Andros Incorporated |
Implantable infusion device
|
|
US4692147A
(en)
|
1980-04-02 |
1987-09-08 |
Medtronic, Inc. |
Drug administration device
|
|
US4327725A
(en)
|
1980-11-25 |
1982-05-04 |
Alza Corporation |
Osmotic device with hydrogel driving member
|
|
US4487603A
(en)
|
1982-11-26 |
1984-12-11 |
Cordis Corporation |
Implantable microinfusion pump system
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4627850A
(en)
|
1983-11-02 |
1986-12-09 |
Alza Corporation |
Osmotic capsule
|
|
EP0154316B1
(en)
|
1984-03-06 |
1989-09-13 |
Takeda Chemical Industries, Ltd. |
Chemically modified lymphokine and production thereof
|
|
DE3424893A1
(de)
|
1984-07-06 |
1986-02-06 |
Agfa-Gevaert Ag, 5090 Leverkusen |
Photographisches silberhalogenidaufzeichnungsmaterial
|
|
US4754065A
(en)
|
1984-12-18 |
1988-06-28 |
Cetus Corporation |
Precursor to nucleic acid probe
|
|
US4683202A
(en)
|
1985-03-28 |
1987-07-28 |
Cetus Corporation |
Process for amplifying nucleic acid sequences
|
|
US4683195A
(en)
|
1986-01-30 |
1987-07-28 |
Cetus Corporation |
Process for amplifying, detecting, and/or-cloning nucleic acid sequences
|
|
GB2183661B
(en)
|
1985-03-30 |
1989-06-28 |
Marc Ballivet |
Method for obtaining dna, rna, peptides, polypeptides or proteins by means of a dna recombinant technique
|
|
US6492107B1
(en)
|
1986-11-20 |
2002-12-10 |
Stuart Kauffman |
Process for obtaining DNA, RNA, peptides, polypeptides, or protein, by recombinant DNA technique
|
|
US4725852A
(en)
|
1985-05-09 |
1988-02-16 |
Burlington Industries, Inc. |
Random artificially perturbed liquid apparatus and method
|
|
US5618920A
(en)
|
1985-11-01 |
1997-04-08 |
Xoma Corporation |
Modular assembly of antibody genes, antibodies prepared thereby and use
|
|
US4800159A
(en)
|
1986-02-07 |
1989-01-24 |
Cetus Corporation |
Process for amplifying, detecting, and/or cloning nucleic acid sequences
|
|
US4865845A
(en)
|
1986-03-21 |
1989-09-12 |
Alza Corporation |
Release rate adjustment of osmotic or diffusional delivery devices
|
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
|
US4704692A
(en)
|
1986-09-02 |
1987-11-03 |
Ladner Robert C |
Computer based system and method for determining and displaying possible chemical structures for converting double- or multiple-chain polypeptides to single-chain polypeptides
|
|
EP0279582A3
(en)
|
1987-02-17 |
1989-10-18 |
Pharming B.V. |
Dna sequences to target proteins to the mammary gland for efficient secretion
|
|
US4873316A
(en)
|
1987-06-23 |
1989-10-10 |
Biogen, Inc. |
Isolation of exogenous recombinant proteins from the milk of transgenic mammals
|
|
US5677425A
(en)
|
1987-09-04 |
1997-10-14 |
Celltech Therapeutics Limited |
Recombinant antibody
|
|
GB8725529D0
(en)
|
1987-10-30 |
1987-12-02 |
Delta Biotechnology Ltd |
Polypeptides
|
|
US5059423A
(en)
|
1988-12-13 |
1991-10-22 |
Alza Corporation |
Delivery system comprising biocompatible beneficial agent formulation
|
|
US5057318A
(en)
|
1988-12-13 |
1991-10-15 |
Alza Corporation |
Delivery system for beneficial agent over a broad range of rates
|
|
EP0401384B1
(en)
|
1988-12-22 |
1996-03-13 |
Kirin-Amgen, Inc. |
Chemically modified granulocyte colony stimulating factor
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
DE3920358A1
(de)
|
1989-06-22 |
1991-01-17 |
Behringwerke Ag |
Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
|
|
SE509359C2
(sv)
|
1989-08-01 |
1999-01-18 |
Cemu Bioteknik Ab |
Användning av stabiliserade protein- eller peptidkonjugat för framställning av ett läkemedel
|
|
US5112614A
(en)
|
1989-09-14 |
1992-05-12 |
Alza Corporation |
Implantable delivery dispenser
|
|
US6075181A
(en)
|
1990-01-12 |
2000-06-13 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
US5686073A
(en)
|
1990-05-23 |
1997-11-11 |
The University Of Iowa Research Foundation |
Polyclonal and monoclonal antibodies against a 43 KDA dystrophin associated protein
|
|
US5580737A
(en)
|
1990-06-11 |
1996-12-03 |
Nexstar Pharmaceuticals, Inc. |
High-affinity nucleic acid ligands that discriminate between theophylline and caffeine
|
|
US5543293A
(en)
|
1990-06-11 |
1996-08-06 |
Nexstar Pharmaceuticals, Inc. |
DNA ligands of thrombin
|
|
US5503978A
(en)
|
1990-06-11 |
1996-04-02 |
University Research Corporation |
Method for identification of high affinity DNA ligands of HIV-1 reverse transcriptase
|
|
US5234692A
(en)
|
1990-07-11 |
1993-08-10 |
Alza Corporation |
Delivery device with a protective sleeve
|
|
US5234693A
(en)
|
1990-07-11 |
1993-08-10 |
Alza Corporation |
Delivery device with a protective sleeve
|
|
EP0542810A1
(en)
|
1990-08-02 |
1993-05-26 |
B.R. Centre Limited |
Methods for the production of proteins with a desired function
|
|
SE9101433D0
(sv)
|
1991-05-13 |
1991-05-13 |
Marianne Hansson |
Recombinant dna sequence and its use
|
|
EP0519596B1
(en)
|
1991-05-17 |
2005-02-23 |
Merck & Co. Inc. |
A method for reducing the immunogenicity of antibody variable domains
|
|
US6797492B2
(en)
|
1991-05-17 |
2004-09-28 |
Merck & Co., Inc. |
Method for reducing the immunogenicity of antibody variable domains
|
|
US5137727A
(en)
|
1991-06-12 |
1992-08-11 |
Alza Corporation |
Delivery device providing beneficial agent stability
|
|
CA2114015C
(en)
|
1991-07-25 |
2002-12-10 |
Roland A. Newman |
Recombinant antibodies for human therapy
|
|
WO1993006126A1
(en)
|
1991-09-13 |
1993-04-01 |
Chiron Corporation |
Immunoreactive hepatitis c virus polypeptide compositions
|
|
US5733761A
(en)
|
1991-11-05 |
1998-03-31 |
Transkaryotic Therapies, Inc. |
Protein production and protein delivery
|
|
DE69232137T2
(de)
|
1991-11-25 |
2002-05-29 |
Enzon Inc |
Multivalente antigen-bindende proteine
|
|
EP1291360A1
(en)
|
1991-12-13 |
2003-03-12 |
Xoma Corporation |
Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
|
|
US5714350A
(en)
|
1992-03-09 |
1998-02-03 |
Protein Design Labs, Inc. |
Increasing antibody affinity by altering glycosylation in the immunoglobulin variable region
|
|
WO1993022332A2
(en)
|
1992-04-24 |
1993-11-11 |
Board Of Regents, The University Of Texas System |
Recombinant production of immunoglobulin-like domains in prokaryotic cells
|
|
ES2249761T3
(es)
|
1993-06-24 |
2006-04-01 |
Advec Inc. |
Vectores de adenovirus para terapia genica.
|
|
EP1637608B1
(en)
|
1993-10-25 |
2009-07-22 |
CANJI, Inc. |
Recombinant adenoviral vector and methods of use
|
|
US5455338A
(en)
|
1993-11-05 |
1995-10-03 |
Zymogenetics, Inc. |
DNA encoding novel human kunitz-type inhibitors and methods relating thereto
|
|
US5827690A
(en)
|
1993-12-20 |
1998-10-27 |
Genzyme Transgenics Corporatiion |
Transgenic production of antibodies in milk
|
|
SE9400088D0
(sv)
|
1994-01-14 |
1994-01-14 |
Kabi Pharmacia Ab |
Bacterial receptor structures
|
|
US7252989B1
(en)
|
1994-04-04 |
2007-08-07 |
Board Of Regents, The University Of Texas System |
Adenovirus supervector system
|
|
US5631146A
(en)
|
1995-01-19 |
1997-05-20 |
The General Hospital Corporation |
DNA aptamers and catalysts that bind adenosine or adenosine-5'-phosphates and methods for isolation thereof
|
|
US5643207A
(en)
|
1995-04-28 |
1997-07-01 |
Medtronic, Inc. |
Implantable techniques for infusing a therapeutic agent with endogenous bodily fluid
|
|
ES2233768T3
(es)
|
1996-02-02 |
2005-06-16 |
Alza Corporation |
Liberacion prolongada de un agente activo utilizando un sistema implantable.
|
|
US5714352A
(en)
|
1996-03-20 |
1998-02-03 |
Xenotech Incorporated |
Directed switch-mediated DNA recombination
|
|
US5820589A
(en)
|
1996-04-30 |
1998-10-13 |
Medtronic, Inc. |
Implantable non-invasive rate-adjustable pump
|
|
US6709659B1
(en)
|
1996-08-02 |
2004-03-23 |
Zymogenetics, Inc. |
Antibodies that bind testis-specific insulin homolog polypeptides
|
|
ES2434961T5
(es)
|
1998-04-20 |
2018-01-18 |
Roche Glycart Ag |
Ingeniería de glicosilación de anticuerpos para mejorar la citotoxicidad celular dependiente del anticuerpo
|
|
WO1999055369A1
(en)
|
1998-04-28 |
1999-11-04 |
Smithkline Beecham Corporation |
Monoclonal antibodies with reduced immunogenicity
|
|
US6696550B2
(en)
|
1998-07-23 |
2004-02-24 |
Millennium Pharmaceuticals, Inc. |
Humanized anti-CCR2 antibodies and methods of use therefor
|
|
US6322788B1
(en)
|
1998-08-20 |
2001-11-27 |
Stanley Arthur Kim |
Anti-bacterial antibodies and methods of use
|
|
AU1728800A
(en)
|
1998-11-18 |
2000-06-05 |
Genentech Inc. |
Antibody variants with higher binding affinity compared to parent antibodies
|
|
US6198966B1
(en)
|
1999-02-26 |
2001-03-06 |
Medtronic, Inc. |
Recirculating implantable drug delivery system
|
|
US6939545B2
(en)
|
1999-04-28 |
2005-09-06 |
Genetics Institute, Llc |
Composition and method for treating inflammatory disorders
|
|
WO2001070266A2
(en)
|
2000-03-17 |
2001-09-27 |
Millennium Pharmaceuticals, Inc. |
Method of inhibiting stenosis and restenosis with a mixture of antibodies anti cd18 and anti ccr2
|
|
JP2004509617A
(ja)
|
2000-09-08 |
2004-04-02 |
シェーリング コーポレイション |
哺乳動物遺伝子；関連試薬および方法
|
|
GB0410866D0
(en)
|
2004-05-14 |
2004-06-16 |
Chiron Srl |
Haemophilius influenzae
|
|
US7527947B2
(en)
|
2004-06-14 |
2009-05-05 |
Novozymes A/S |
Signal peptide for producing a polypeptide
|
|
AU2005325801A1
(en)
|
2005-01-31 |
2006-08-03 |
Ablynx N.V. |
Method for generating variable domain sequences of heavy chain antibodies
|
|
US7119179B1
(en)
|
2005-03-21 |
2006-10-10 |
Los Alamos National Security, Llc |
Preparation of high nitrogen compound and materials therefrom
|
|
US10155816B2
(en)
|
2005-11-28 |
2018-12-18 |
Genmab A/S |
Recombinant monovalent antibodies and methods for production thereof
|
|
EP1980269A1
(en)
|
2007-04-13 |
2008-10-15 |
Katholieke Universiteit Leuven |
Prevention of staphylococcus biofilm formation
|
|
MX2012010793A
(es)
*
|
2010-03-29 |
2013-05-09 |
Univ Southern California |
Composiciones y metodos para la eliminacion de biopeliculas.
|
|
EP2613797B1
(en)
|
2010-09-09 |
2015-11-04 |
University Of Southern California |
Compositions and methods for the removal of biofilms
|
|
US9746475B2
(en)
|
2011-03-14 |
2017-08-29 |
University Of Southern California |
Antibody and antibody mimetic for visualization and ablation of endogenous proteins
|
|
US10722577B2
(en)
*
|
2012-05-25 |
2020-07-28 |
Sloan Kettering Institute For Cancer Research |
Methods for treating GI syndrome and graft versus host disease
|
|
AU2013359262C1
(en)
|
2012-12-12 |
2021-05-13 |
Massachusetts Institute Of Technology |
CRISPR-Cas component systems, methods and compositions for sequence manipulation
|
|
US20160194384A1
(en)
|
2014-06-12 |
2016-07-07 |
Research Institute At Nationwide Children's Hospital |
Compositions and methods for the removal of biofilms
|
|
CA2915210A1
(en)
|
2013-06-13 |
2014-12-18 |
Research Institute At Nationwide Children's Hospital |
Compositions and methods for the treatment of burkholderia infections
|
|
US11274144B2
(en)
|
2013-06-13 |
2022-03-15 |
Research Institute At Nationwide Children's Hospital |
Compositions and methods for the removal of biofilms
|
|
US9745366B2
(en)
|
2013-09-23 |
2017-08-29 |
University Of Southern California |
Compositions and methods for the prevention of microbial infections
|
|
US11248040B2
(en)
|
2013-09-26 |
2022-02-15 |
Trellis Bioscience, Llc |
Binding moieties for biofilm remediation
|
|
US20150197558A1
(en)
|
2013-09-26 |
2015-07-16 |
Trellis Bioscience, Llc |
Binding moieties for biofilm remediation
|
|
US10233234B2
(en)
|
2014-01-13 |
2019-03-19 |
Trellis Bioscience, Llc |
Binding moieties for biofilm remediation
|
|
US20150299298A1
(en)
|
2013-09-26 |
2015-10-22 |
Trellis Bioscience, Llc |
Binding moieties for biofilm remediation
|
|
US20150086561A1
(en)
|
2013-09-26 |
2015-03-26 |
Trellis Bioscience, Llc |
Binding moieties for biofilm remediation
|
|
BR112016013514B1
(pt)
|
2013-12-13 |
2022-04-19 |
Stora Enso Oyj (Fi) |
Papelão de múltiplas camadas
|
|
EP3049113B1
(en)
|
2014-01-13 |
2023-12-27 |
Trellis Bioscience, LLC |
Binding moieties for biofilm remediation
|
|
WO2016154491A1
(en)
|
2015-03-25 |
2016-09-29 |
Trellis Bioscience, Llc |
Binding moieties for biofilm remediation
|
|
AU2016303688B2
(en)
*
|
2015-07-31 |
2023-06-15 |
Research Institute At Nationwide Children's Hospital |
Peptides and antibodies for the removal of biofilms
|
|
WO2017066719A2
(en)
|
2015-10-14 |
2017-04-20 |
Research Institute At Nationwide Children's Hospital |
Hu specific interfering agents
|
|
AU2016365423A1
(en)
*
|
2015-12-04 |
2018-07-12 |
The Regents Of The University Of California |
Novel antibodies for the treatment of cancers
|
|
WO2017192594A1
(en)
*
|
2016-05-02 |
2017-11-09 |
Trellis Bioscience, Llc |
Binding moieties for biofilm remediation
|
|
JP2019530440A
(ja)
|
2016-09-02 |
2019-10-24 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
インターロイキン６受容体α結合単鎖可変断片を含む方法および組成物
|
|
AU2018206560B9
(en)
|
2017-01-04 |
2025-04-03 |
Research Institute At Nationwide Children's Hospital |
Antibody fragments for the treatment of biofilm-related disorders
|
|
JP7514621B2
(ja)
|
2017-01-04 |
2024-07-11 |
リサーチ インスティチュート アット ネイションワイド チルドレンズ ホスピタル |
Ｄｎａｂｉｉワクチンおよび強化された活性を有する抗体
|
|
US12084514B2
(en)
|
2017-12-04 |
2024-09-10 |
The Board Of Regents Of The University Of Oklahoma |
Anti-DCLK1 antibodies and chimeric antigen receptors, and compositions and methods of use thereof
|
|
WO2021007260A2
(en)
|
2019-07-08 |
2021-01-14 |
Research Institute At Nationwide Children's Hospital |
Antibody compositions for disrupting biofilms
|